The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up
Sign Up to like & getrecommendations! Published in 2017 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2017.02.005
Abstract: Highlights • NACT use among SGO members for ovarian cancer is explored given recent trials.• Fewer SGO members feel they can't predict optimal cytoreduction pre-operatively.• Laparoscopy use has increased both for diagnosis and treatment of… read more here.
Keywords: chemotherapy management; sgo members; ovarian cancer; neoadjuvant chemotherapy ... See more keywords
The role of neoadjuvant chemotherapy in elderly patients with borderline or locally advanced pancreatic cancer: Is it safe and feasible?
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.4_suppl.685
Abstract: 685Background: For borderline resectable (BRPC) or locally advanced pancreatic cancer (LAPC), neoadjuvant (NAT) FOLFIRINOX or gemcitabine plus nab-paclitaxel (GnP) are standard treatment options an... read more here.
Keywords: advanced pancreatic; pancreatic cancer; neoadjuvant chemotherapy; role neoadjuvant ... See more keywords
The Evolving Role of Neoadjuvant Therapy for Operable Breast Cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2022.7016
Abstract: The role of neoadjuvant therapy (NAT) for localized breast cancer has evolved tremendously over the past several years. Currently, NAT is the preferred option for high-risk early triple-negative (TN) and HER2-positive (HER2+) breast cancers and… read more here.
Keywords: neoadjuvant therapy; escalation; breast; role neoadjuvant ... See more keywords